SAO · DASA3.SA
Diagnósticos da América S.A.
R$3.01+R$0.06 (+2.03%)
Diagnósticos da América S.A.’s quoted price sits in the lower half of its reported 52-week range, 48.01% below the high.
Loading market information…
SAO · BLAU3.SA · BRL
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:06 PM UTC. Cached market data; not a live quote.
One-year closing-price history · BRL. Historical prices are not a forecast.
Blau Farmacêutica S.A.’s quoted price sits in the lower half of its reported 52-week range, 36.9% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Blau Farmacêutica S.A.’s forward annual dividend is R$0.30 per share, paid quarterly. The forward yield is 3.31% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Blau Farmacêutica S.A.’s next earnings report is currently expected on Nov 10, 2026, with estimated earnings per share of R$0.30. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Blau Farmacêutica S.A.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Blau Farmacêutica S.A. operates as a pharmaceutical enterprise, supplying private label medications across Brazil, Argentina, Colombia, the United States, Ecuador, Peru, and Uruguay. Its extensive product portfolio encompasses a broad spectrum of therapeutic areas, including immunology, hematology, oncology, nephrology, specialized treatments, and antibiotics. The company's offerings also extend to biological drugs, oral and injectable therapies for cancer, specialized treatments for infectious diseases, and a range of prescription and over-the-counter products like dermo-medicines and contraceptives, catering to both retail and non-retail markets. Additionally, Blau provides pharmaceuticals derived from blood, biological and biotechnological agents, and antiretroviral drugs. Its client base includes hospitals, private medical clinics, chemotherapy and hemodialysis centers, and public health institutions. Established in 1987, the firm's corporate headquarters are situated in Cotia, Brazil.
Latest available per-share figures in BRL. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:23 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | May 7, 2025 | R$0.51+53.64% vs estimate | R$373.00M-22.43% vs estimate |
|---|
| Q4 2024 | Mar 19, 2025 | R$0.32-5.88% vs estimate | R$456.03M+20.25% vs estimate |
|---|
| Q3 2024 | Nov 6, 2024 | R$0.39+25.81% vs estimate | R$473.57M+2.73% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
R$3.01+R$0.06 (+2.03%)
Diagnósticos da América S.A.’s quoted price sits in the lower half of its reported 52-week range, 48.01% below the high.
R$2.50-R$0.06 (-2.34%)
Empreendimentos Pague Menos S.A.’s quoted price sits in the lower half of its reported 52-week range, 67.19% below the high.
R$10.11-R$0.18 (-1.75%)
Dimed S.A. Distribuidora de Medicamentos’s quoted price sits in the lower half of its reported 52-week range, 38.99% below the high.
R$0.76+R$0.05 (+7.04%)
Oncoclínicas do Brasil Serviços Médicos S.A.’s quoted price sits in the lower half of its reported 52-week range, 75.24% below the high.
R$6.60-R$0.00 (0.0%)
Profarma Distribuidora de Produtos Farmacêuticos S.A.’s quoted price sits in the lower half of its reported 52-week range, 31.96% below the high.
R$5.37+R$0.02 (+0.37%)
Biomm S.A.’s quoted price sits in the lower half of its reported 52-week range, 44.92% below the high.
R$2.49+R$0.03 (+1.22%)
Allianca Saude e Participacoes S.A.’s quoted price sits in the lower half of its reported 52-week range, 59.77% below the high.
R$1.33+R$0.03 (+2.31%)
Qualicorp Consultoria e Corretora de Seguros S.A.’s quoted price sits in the lower half of its reported 52-week range, 51.28% below the high.
